Hello All I really believe in this company I have followed it since it was in the 1.75 range and see nothing but growth here. there is 60k eye docs and they have only 500-1000 signed up atm so if they can do 500 doc per year this stock should double if not more each year. More if the amount of shorts keep shorting LOL But I really see 30% of docs in the near future getting in so huge upside here. Numbers are going to be huge. This stock should be at $10 for every 1000 docs
The TearLab Osmolarity System is the Gold Standard for diagnosing and managing Dry Eye Disease with a quantitative, objective endpoint. CMS Reimbursement - $46.80 per patient (in the U.S. only). CPT Code 83861. FDA 510(k) cleared. CLIA Waived. CE Marked.